請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/24321
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林亮音(Liang-In Lin) | |
dc.contributor.author | Wann-Cheng Lo | en |
dc.contributor.author | 羅婉臻 | zh_TW |
dc.date.accessioned | 2021-06-08T05:21:52Z | - |
dc.date.copyright | 2005-08-02 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-07-26 | |
dc.identifier.citation | American College of Rheumatology “Patient Education” http://www.rheumatology.org/public/factsheets/ra.asp (April 2003)
Anderson JJ, Wells G, Verhoeven AC, et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000; 43: 22-9. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000; 343: 1586-93. Berger CE, Krönera AH, Minai-Pour MB et al. Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone. 2003; 33: 346-51. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18. Bonde M, Qvist P, Fledelius C, Riis BJ, et al. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994; 40: 2022-5. Boutry N, Hachulla E, Flipo RM et al. MR Imaging Findings in Hands in Early Rheumatoid Arthritis: Comparison with Those in Systemic Lupus Erythematosus and Primary Sjogren Syndrome. Radiology 2005, 10.1148/radiol.2361040844. RSNA, 2005 Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999; 26: 717–9. Brower AC. Use of the radiograph to measure the course of rheumatoid arthritis: the gold standard versus fool’s gold. Arthritis Rheum 1990; 33: 316-24. Buckland-Wright JC, Clarke GS, Chikanza IC, et al. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol 1993; 20: 243-7. Bukhari M, Lunt M, Harrison BJ, et al. Rheumatoid Factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Arthritis Rheum 2002; 46: 906-12. Charni N, Burge D, Garnero P. Uncoupling of bone formation and bone resorption as assessed by serum osteocalcin and C-terminal crosslinking telopeptide of type I collagen predicts radiographic progression in patients with early rheumatoid arthritis. Ann Rheum Dis 2003; 62(suppl 1): 329. Combe B and Hazes JMW. Early rheumatoid arthritis: the importance of early diagnosis and treatment. Best Practice & Research Clinical Rheumatology 2005; 19: vii. Delmas PD, Wahner HW, Mann KG, et al. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med 1983; 102: 470-6. Devauchelle Pensec V, Saraux A, Berthelot JM, et al. Ability of hand radiographs to predict a further diagnosis of rheumatoid arthritis in patients with early arthritis. J Rheumatal 2001; 28: 2603-7 Dörner T. and Hansen A. Autoantibodies in normals – the value of predicting rheumatoid arthritis. Arthritis Res Ther 2004; 6: 282-4. Egsmose C, Lund B, Borg G, et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995; 22: 2208-13. Eyre DR, Wu JJ, Woods PE et al. The cartilage collagnes: Structural and metabolic studies. J Rheumatol 18 (Suppl. 27): 49-51 Firestein GS, Paine MM, and Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement and HLA-DR) in rhteumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34: 1094-105. Firestein GS. Etilogy and pathogenesis of rheumatoid arthritis. Ruddy S, Harris ED, Sledge CB, editors, Kelly’s textbook of rheumatology. Philadelohia: W.B. Saunders: 921-66. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-61. Fransen J, Stucki G, and Piet LCM van Riel. Rheumatoid arthritis measures-disease activity score (DAS), disease activity score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI). Arthritis Rheum 2003; 49: S214-24. Garnero P and Delmas PD. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers. Current Opinion in Rheumatology 2004; 16: 428-34. Garnero P, Gineyts E, Christgau S, Finck B, et al. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum. 2002; 46: 21-30 Garnero P, Jouvenne P, Buchs N, et al. Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products. Bone 1999; 24: 381-5. Garnero P, Landewe R, Boers M, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002; 46: 2847-56. Garnero P, Mazieres B, Gueguen A, et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005; 32: 697-703. Garnero P, Rousseau JC, and Delmas PD. Molecular basis and clinical use of biochemical marker of bone, cartilage, and synovium in joint disease. Arthritis Rheum 2000; 43: 953-68. Giovagnoni A, Valeri G, Burroni E, et al. Rheumatoid arthritis: follow-up and response to treatment. Genet Epidemics 1999; 27:25-30 Goldbach-Mansky R, Lee J, McCoy A, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236-43. Goronzy JJ, Matteson EL, Fulbright JW, et al. Prognostic Markers of Radiographic Progression in Early Rheumatoid Arthritis. Arthritis Rheum 2004; 50: 43-54 Green MJ, Gough AK, Devlin J, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology 2003; 42: 83-8. Guillemin F, Billot L, Boini S, et al. Reproducibility and sensitivity to change of 5 methods for scoring hand radiographic damage in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 778-86. Jansen ALMA, Van der Horst-Bruinsma IE, Van Schaardenburg D, et al. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002; 29: 2074-76. Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D et al. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis. 2001; 60: 924-7. Johansen JS, Jensen HS, and Price PA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993; 32: 949–55. Johansen JS, Kirwan JR, Price PA et al. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. Scand J Rheumatol. 2001; 30: 297-304. Kaneko M, Tomita T, Nakase T, et al. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology 2001; 40: 247–55. Keyszer G, Lambirini I, Nagel R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinase 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease: correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999; 26: 251-8. Knott L, and Bailey AJ. Collagen cross-links in mineralizing tissues: A review of their chemistry, function, and clinical relevance. Bone 1998; 22: 181-7 Kopaliani M. Assessment of cortical bone mineral density and biochemical markers of bone metabolism in postmenopausal osteoporosis. Georgian Med News. 2005; 5: 33-6. Kroot EJJA, de Jong BAW, van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheyumatoid arthritis. Arthritis Rheum 2000; 43: 1831-35 Lab Tests Online http://www.labtestsonline.org/understanding/analytes/rheumatoid/test.html (October 2003) Landewe RBM, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46: 347-56. Lee J, Lee SK, Suh JS et al. Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis. J Rheumatol 1997; 24: 1303-8. Lundberg K, Nijenhuis S, Vossenaar ER, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005; 7: R458-67. Machold KP, Stamm TA, Eberl GJ, et al.: Very recent onset arthritis—clinical, laboratory and radiological findings during the first year of disease. J Rheum 2002; 29: 2278-87. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular Death in Rheumatoid Arthritis- A Population-Based Study. Arthritis Rheum 2005; 52: 722-32. Matsumoto T, Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters. Clin Exp Rheumatol. 2001;19: 655-60. McQueen FM, Benton N, Perry D, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 1814-27. McQueen F, Lassere M, Edmonds J, et al. OMERACT Rheumatoid Arthritis Magnetic Resonace Imaging Studies. Summary of OMERACT 6 MR imaging module. J Rheumatol 2003; 30: 1387-92 McQueen F, Stewart N, Crabble J et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999; 58: 156-63 Mouritzen U, Christgau S, Lehmann H-J, et al. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis 2003; 62: 332-6. Munro R, Hampson R, McEntegart A, et al. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis 1998; 57: 88-93. Nagase H and Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-4. National Institute of Arthritis and Musculoskeletal and Skin Disease. “Question and answers about arthritis pain” 2001. http://www.niams.nih.gov/hi/topics/arthritis/arthpain.htm (14 May 2003) Nicola PJ, Maradit-Kremers H, Roger VL, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 412-20. Nielen MMJ, Van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6. O’Dell JR. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 2002; 46: 283-5. Ostanek L, Pawlik A, Brzosko I, et al. The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab. Clin Rheumatol 2004; 23: 214-7. Ostergaard M and Ejbjerg Bo. Magnetic Resonance Imaging of the Synovium in Rheumatoid Arthritis. Semin Musculoskelet Radiol 2004; 8: 287-99 Ostergaard M, Edmonds J, McQueen F, et al. An introduction to the EULAR- OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005; 64: i3-7. Peterfy CG. Imaging in rheumatoid arthritis. Curr Opin Rheumatol 2003; 15: 288–95. Peterfy CG. MRI of the wrist in early rheumatoid arthritis. Ann Rheum Dis 2004; 63: 473-477. Posthumus MD, Limburg PC, Westra J, et al. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 465-72. Rammelt S, Neumann M, Hanisch U, et al. Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J Biomed Mater Res 2005; 73A: 284-94 Rau R. and Wassenberg S.. Reliability of scoring methods to measure radiographic change. J Rheumatol 2005; 32: 766-8. Rodan GA and Rodan SB. The cells of bone. Osteoporosis: etiology, diagnosis and management. Riggs BL and Melton LJIII, eds., 2nd edition, Lippincott-Raven, Philadelphia, 1995: 1-40. Rothschild, B. M., Turner, K. R. & DeLuca, M. A. Symmetrical erosive peripheral polyarthritis in theLate Archaic Period of Alabama. Science 1988; 241: 1498-1501. Schellekens GA, Visser H, De Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cycle cirtrullunated peptide. Arthritis Rheum 2000; 43: 155-63. Scott DL, Laasonen L, Priolo F, et al. The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol 1997; 15: S53-61. Shelllekens GA, De Jong BA, Van de Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinates recognized by rheumatoid arthritis-specific antibodies. J Clin Invest 1998; 101: 273-81. Singer JM, and Plotz CM. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med 1956; 21: 888-92. Smolen JS and Steiner G. Therapeutic strategies for rheumatoid arthritis. Nature Rev Drug Discovery 2002; 2: 473-88. Symmons DPM, Jones MA, Scott DL, et al. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998; 25: 1072-7. Tanaka N, Sakahashi H, Ishii S et al. Synovial membrane enhancement and bone erosion by magnetic resonance imaging for prediction of radiologic progression in patients with early rheumatoid arthritis. Rheumatol Int. 2005; 25:103-7. Tehranzadeh J, Ashikyan O, Dascalos J. Advanced imaging of early rheumatoid arthritis. Radiol Clin North Am 2004; 42: 89-107. Tonolli-Serabian I, Poet J, Dufour M, et al. Magnetic resonance imaging of the wrist in rheumatoid arthritis: comparison with other inflammatory joint diseases and control subjects. Clin Rheumatol 1996; 15: 137-42. Tugwell P and Boers M. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol 1993; 20: 528-30. Van der Heide A, Jacobs JWG, Bijlsma JWJ, et al. The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996; 124: 699-707. Van der Heijde D, Dankert T, Nieman F, et al. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology 1999; 38: 941-7. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method? J Rheumatol 1999; 26: 743-5. Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004, 50: 709-15. Van Gestel AM, Prevoo ML, van’t Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34-40. Van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002; 60: 383-8. Verheijden GF, Rijnders AW, Bos E, Coenen-de Roo CJ et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum1997; 40: 1115-25. Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Method Mol Biol 2001; 151: 121-148. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357-65. Volck B, Johansen JS, Stoltenberg M et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage. 2001; 9: 203-14. Wakefield RJ, Conaghan PG, Jarrett S, et al. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: imaging technique Curr Opin Rheumatol 2004; 16: 435-42 Walsh Nicole C and Gravallese Ellen M. Bone loss in inflammatory arthritis: mechanisms and treatment strategies. Curr Opin Rheumatol 2004; 16: 419-27. Welsing PM, Landewe RB, van Riel PL et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum. 2004; 50: 2082-93. Wollheim FA, Eberhardt KB, Johnson U, et al. HLA DRB1 typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis. Br J Rheumatol 1997; 36: 847-9. Yamada R. Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis. Autoimmun Rev 2005; 4: 201-6. Zeisel MB, Druet VA, Wachsmann D, et al. MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrinα5β1. Athritis Res Ther. 2005; 7: R118-26. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/24321 | - |
dc.description.abstract | 類風溼性關節炎(Rheumatoid arthritis)為一種慢性、進行性以關節及其周圍組織侵犯為主的免疫疾病。早期通常為多發性、對稱性的關節炎,可引起關節的破壞與侵蝕,繼而造成關節的畸形與功能損傷,造成病人生活不便。傳統的檢查技術(包括serum CRP和ESR),甚至影像方法(包括核磁共振與X-光照影),皆無法提供區域性骨侵蝕或全身性骨骼流失的正確資訊。故在此研究當中,我們收集36位病人,分析其28處關節疾病活動度積分(DAS28)、X-光(Sharp score)、以及十個血清或尿液的生化指標。其中20位病人繼續追蹤九個月,進行四次核磁共振分析(骨侵蝕、骨髓水腫和滑膜炎),發現核磁共振和X-光在四個時間點所偵測的骨侵蝕程度,在個別時間點並無明顯差異,代表在這九個月的追蹤期間,病人骨骼並無明顯變化。在此36位病人當中,DAS28與關節間隙狹窄 (JSN of Sharp score)存在著很高的相關性;同時,核磁共振的骨侵蝕與ERO也有高度相關。當分析基準點時的36位病人資料,則發現DAS28與CRP和PYD存在有有高度的相關性,Sharp scores與urinary CTX-I、YKL-40和PYD呈現高度相關。若進一步分析追蹤20位病人的個別資料,則發現其中有三位病人顯示相同的高相關性結果。在核磁共振影像方面, 20個病人在四個時間點所收集到的資料進行分析,則發現發現骨侵蝕高度相關於COMP、anti-CCP、osteocalcin和urinary CTX-II。骨髓水腫與osteocalcin和urinary CTX-II亦呈現高度之相關性,滑膜炎則是與urinary CTX-I相關。若進一步將所有時間數據整合,只剩下anti-CCP、osteocalcin、urinary CTX-I、YKL-40和urinary CTX-II與核磁共振影像具有相關性。 | zh_TW |
dc.description.abstract | Rheumatoid arthritis (RA) is a chronic and potentially crippling disease characterized by systemic inflammation, bone erosion and joint tissue degradation. Laboratory tests (serum CRP and ESR) and even imaging methods (magnetic resonance imaging [MRI] and radiography) can not provide accurate information for local bone erosion or systemic bone loss. In the present study, thirty six RA patients were examined by disease activity using index 28 (DAS28), radiography (Sharp score), and measurement of ten biomarkers. The Sharp scores and MRI images were carefully scored. Twenty patients of thirty-six patients were continuously followed-up for 9 month periods. The results showed no significant difference of data at the four time points in the 20 patients. However, DAS28 showed clear correlations with joint space narrowing [JSN] of Sharp scores and MRI edema, while MRI erosion scores was correlated well with erosion of Sharp score [ERO] on radiography. Further investigation of data at baseline of 36 patients suggested that CRP and pyridinoline [PYD] can also be correlated well with DAS28, meanwhile urinary C-terminal telopeptide of type I collagen [CTX-I], YKL-40 and PYD demonstrated good correlations with Sharp score. The individual data of three RA patients, collected during the following six months, confirmed this high correlation between PYD, YKL-40 and Sharp scores. In MRI features at four time points in 20 patients, close relationships have also been found in between “erosions” and cartilage oligomeric matrix protein [COMP], anti-cyclic citrullinated peptide antibody [CCP], osteocalcin and urinary C-terminal telopeptide of type II collagen [CTX-II]; “edema” and osteocalcin and urinary CTX-II; “synovitis' and urinary CTX-I. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T05:21:52Z (GMT). No. of bitstreams: 1 ntu-94-R92424013-1.pdf: 1724214 bytes, checksum: 5c77d9f83fbf94d494b5c52d6480aa39 (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | Abbreviations 1
English Abstract 3 Chinese Abstract 4 Chapter One Introduction 5 Chapter Two Purpose 16 Chapter Three Materials and Methods 17 Chapter Four Results 39 Chapter Five Discussions 44 Chapter Six Summary 50 Acknowledgement 51 Figures 52-58 Tables 59-69 References 70 Appendix 78-90 | |
dc.language.iso | en | |
dc.title | 建立評估類風溼性關節炎病人之關節損壞程度的生物標誌 | zh_TW |
dc.title | Develop Biomarkers for Assessing Joint Erosion of Rheumatoid Arthritis | en |
dc.type | Thesis | |
dc.date.schoolyear | 93-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 余家利(Chia-Li Yu),王崇禮(Chung-Li Wang),曾文毅(Wen-Yih Tseng),張啟仁(Chi-jen Chang) | |
dc.subject.keyword | 類風濕性關節炎,核磁共振,生物標誌,X-光, | zh_TW |
dc.subject.keyword | Rheumatoid Arthritis,RA,biomarkers,MRI,radiography,bone erosion, | en |
dc.relation.page | 92 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2005-07-26 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 醫事技術學研究所 | zh_TW |
顯示於系所單位: | 醫學檢驗暨生物技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 1.68 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。